Abstract | AIMS: METHODS AND RESULTS: To study this, mice hearts were perfused in Langendorff mode for 40 min of baseline and subjected to 20 or 30 min of global no-flow ischemia followed by 40 min of reperfusion. C57BL6 mice perfused with 11,12-EET (1 μM) had improved postischemic recovery, whereas co-perfusion with PI3Kα inhibitor, PI-103 (0.1 μM), abolished the EET-mediated effect. In contrast, blocking of PI3Kβ or PI3Kγ isoforms failed to inhibit EET-mediated cardioprotection. In addition to the improved post-ischemic recovery, increased levels of p-Akt, decreased calcineurin activity and decreased translocation of proapoptotic protein BAD to mitochondria were noted in EET-treated hearts. Perfusion of 11,12-EET to Kir6.2 deficient mice (pmK( ATP)) failed to improve postischemic recovery, decrease calcineurin activity and translocation of proapoptotic protein BAD, however increased levels of p-Akt were still observed. Patch-clamp experiments demonstrated that 11,12-EET could not activate pmK( ATP) currents in myocytes pre-treated with PI-103. Mechanistic studies in H9c2 cells demonstrate that 11,12-EET limits anoxia-reoxygenation triggered Ca(2+) accumulation and maintains mitochondrial ΔΨm compared to controls. Both PI-103 and glibenclamide (10 μM, pmK( ATP) inhibitor) abolished EET cytoprotection. CONCLUSION: Together our data suggest that EET-mediated cardioprotection involves activation of PI3Kα, upstream of pmK( ATP), which prevents Ca(2+) overload and maintains mitochondrial function.
|
Authors | Sri N Batchu, Ketul R Chaudhary, Haitham El-Sikhry, Wei Yang, Peter E Light, Gavin Y Oudit, John M Seubert |
Journal | Journal of molecular and cellular cardiology
(J Mol Cell Cardiol)
Vol. 53
Issue 1
Pg. 43-52
(Jul 2012)
ISSN: 1095-8584 [Electronic] England |
PMID | 22561102
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cardiotonic Agents
- Isoenzymes
- KATP Channels
- 11,12-epoxy-5,8,14-eicosatrienoic acid
- Class Ia Phosphatidylinositol 3-Kinase
- 8,11,14-Eicosatrienoic Acid
- Calcium
|
Topics |
- 8,11,14-Eicosatrienoic Acid
(analogs & derivatives, pharmacology)
- Animals
- Calcium
(metabolism)
- Cardiotonic Agents
(pharmacology)
- Cell Line
- Class Ia Phosphatidylinositol 3-Kinase
(metabolism)
- Heart
(drug effects)
- Hypoxia
- Isoenzymes
(metabolism)
- KATP Channels
(metabolism)
- Membrane Potential, Mitochondrial
(drug effects)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myocardial Reperfusion Injury
(metabolism, physiopathology, prevention & control)
- Myocardium
(enzymology, metabolism)
- Sarcolemma
(enzymology, metabolism)
|